Nuvectis Pharma
(NASDAQ) NVCT
Nuvectis Pharma Financials at a Glance
Market Cap
$618.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$27.16M
EPS (TTM)
-$1.28
P/E Ratio
-15.40
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$19.73
Volume
572,417.42
Open
$20.57
Price
$19.73
Volume
572,417.42
Open
$20.57
Previous Close
$19.63
Daily Range
$19.61 - $20.74
52-Week Range
$5.55 - $29.28
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$19.73
Volume
572,417.42
Open
$20.57
Previous Close
$19.63
Daily Range
$19.61 - $20.74
52-Week Range
$5.55 - $29.28
Estimated Earnings Date
Aug 4, 2026
NVCT News
NVCT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nuvectis Pharma
Industry
Biotechnology
Sector
Health CareEmployees
12
CEO
Ronald E. Bentsur, MBA
Website
www.nuvectis.comHeadquarters
Fort Lee, NJ 07024, US
NVCT Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-147.78%
Return on Capital
-149.75%
Return on Assets
-106.94%
Earnings Yield
-6.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$618.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
31.53M
Volume
572.42K
Avg. Volume
235.64K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$28.27M
EBITDA
-$28.06M
Operating Cash Flow
-$18.35M
Capital Expenditure
$0.00
Free Cash Flow
-$18.35M
Cash & ST Invst.
$25.13M
Total Debt
$0.00
Nuvectis Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$618.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$47.60M
N/A
Employees
13
N/A
Net Income
-$6.05M
-13.5%
EBITDA
-$6.05M
-13.5%
Quarterly Fundamentals
Total Cash
$25.13M
-15.9%
Total Debt
$0.00
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.07%
N/A
Return on Invested Capital
-1.99%
N/A
Free Cash Flow
-$6.51M
-56.0%
Operating Cash Flow
-$6.51M
-56.0%